These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 10810240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H, Narita M, Wu H, Narita M, Suzuki T, Nagase H, Tseng LF.
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 7. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M, Khotib J, Suzuki M, Ozaki S, Yajima Y, Suzuki T.
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR, Clark MJ, Remmers AE.
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T, Tseng LF.
    J Neurosci; 2001 Jun 01; 21(11):3715-20. PubMed ID: 11356858
    [Abstract] [Full Text] [Related]

  • 14. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M, Narita M, Mizoguchi H, Narita M, Ohsawa M, Kamei J, Nagase H, Takeda H, Matsumiya T, Tseng LF.
    Life Sci; 1999 Jun 01; 65(16):PL233-9. PubMed ID: 10573190
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M, Mizoguchi H, Nagase H, Suzuki T, Tseng LF.
    Brain Res; 2001 Sep 21; 913(2):170-3. PubMed ID: 11549382
    [Abstract] [Full Text] [Related]

  • 16. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
    Sim-Selley LJ, Daunais JB, Porrino LJ, Childers SR.
    Neuroscience; 1999 Sep 21; 94(2):651-62. PubMed ID: 10579225
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2001 Jul 21; 298(1):116-21. PubMed ID: 11408532
    [Abstract] [Full Text] [Related]

  • 18. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
    Mizoguchi H, Narita M, Oji DE, Suganuma C, Nagase H, Sora I, Uhl GR, Cheng EY, Tseng LF.
    Neuroscience; 1999 Jul 21; 94(1):203-7. PubMed ID: 10613510
    [Abstract] [Full Text] [Related]

  • 19. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 21; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 20. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
    Hosohata K, Burkey TH, Alfaro-Lopez J, Varga E, Hruby VJ, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1998 Apr 03; 346(1):111-4. PubMed ID: 9617760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.